Intravenous Immunoglobulin Market Generating Revenue of USD 24.13 Billion by 2032, At a Booming 7.50% Growth Rate

The market was valued at USD 12.66 billion in 2023 and is expected to grow to USD 24.13 billion by 2032 at a CAGR of 7.50% during the forecast period.

Intravenous Immunoglobulin Market Generating Revenue of USD 24.13 Billion by 2032, At a Booming 7.50% Growth Rate